Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 22 articles:
HTML format
Text format



Single Articles


    October 2017
  1. WEN S, Wang J, Liu P, Li Y, et al
    Novel combination of histone methylation modulators with therapeutic synergy against acute myeloid leukemia in vitro and in vivo.
    Cancer Lett. 2017 Oct 22. pii: S0304-3835(17)30650.
    PubMed     Text format     Abstract available


    September 2017
  2. COLLADO R, Puiggros A, Lopez-Guerrero JA, Calasanz MJ, et al
    Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes.
    Cancer Lett. 2017 Sep 6. pii: S0304-3835(17)30536.
    PubMed     Text format     Abstract available


  3. SADRAS T, Heatley SL, Kok CH, Dang P, et al
    Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions.
    Cancer Lett. 2017 Sep 1. pii: S0304-3835(17)30521.
    PubMed     Text format     Abstract available


    August 2017
  4. PRIGOZHINA TB, Szafer F, Aronin A, Tzdaka K, et al
    Fn14.TRAIL fusion protein is oligomerized by TWEAK into a superefficient TRAIL analog.
    Cancer Lett. 2017;400:99-109.
    PubMed     Text format     Abstract available


    July 2017
  5. MOHARRAM SA, Shah K, Khanum F, Marhall A, et al
    Efficacy of CDK inhibitor dinaciclib in vitro and in vivo in T-cell acute lymphoblastic leukemia.
    Cancer Lett. 2017 Jul 26. pii: S0304-3835(17)30455.
    PubMed     Text format     Abstract available


    April 2017
  6. ESPINOZA JL, Elbadry MI, Taniwaki M, Harada K, et al
    The simultaneous inhibition of the mTOR and MAPK pathways with Gnetin-C induces apoptosis in acute myeloid leukemia.
    Cancer Lett. 2017 Apr 26. pii: S0304-3835(17)30288.
    PubMed     Text format     Abstract available


    February 2017
  7. GAZI M, Moharram SA, Marhall A, Kazi JU, et al
    The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL).
    Cancer Lett. 2017 Feb 1. pii: S0304-3835(17)30077.
    PubMed     Text format     Abstract available


  8. PIAO J, Takai S, Kamiya T, Inukai T, et al
    Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cells.
    Cancer Lett. 2017;386:131-140.
    PubMed     Text format     Abstract available


    December 2016
  9. TURPIN J, Alais S, Marcais A, Bruneau J, et al
    Whole body clonality analysis in an aggressive STLV-1 associated leukemia (ATLL) reveals an unexpected clonal complexity.
    Cancer Lett. 2016 Dec 26. pii: S0304-3835(16)30785.
    PubMed     Text format     Abstract available


  10. WU Y, Giaisi M, Kohler R, Chen WM, et al
    Rocaglamide breaks TRAIL-resistance in human multiple myeloma and acute T-cell leukemia in vivo in a mouse xenogtraft model.
    Cancer Lett. 2016 Dec 18. pii: S0304-3835(16)30763.
    PubMed     Text format     Abstract available


    October 2016
  11. GUPTA P, Kathawala RJ, Wei L, Wang F, et al
    PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.
    Cancer Lett. 2016 Oct 5. pii: S0304-3835(16)30567.
    PubMed     Text format     Abstract available


    September 2016
  12. HE SJ, Shu LP, Zhou ZW, Yang T, et al
    Inhibition of Aurora kinases induces apoptosis and autophagy via AURKB/p70S6K/RPL15 axis in human leukemia cells.
    Cancer Lett. 2016 Sep 6. pii: S0304-3835(16)30491.
    PubMed     Text format     Abstract available


    April 2016
  13. HUANG A, Ju H, Liu K, Zhan G, et al
    Metabolic alterations and drug sensitivity of tyrosine kinase inhibitor resistant leukemia cells with a FLT3/ITD mutation.
    Cancer Lett. 2016 Apr 28. pii: S0304-3835(16)30276.
    PubMed     Text format     Abstract available


  14. LU JW, Wang AN, Liao HA, Chen CY, et al
    Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD).
    Cancer Lett. 2016 Apr 6. pii: S0304-3835(16)30217.
    PubMed     Text format     Abstract available


    March 2016
  15. GARCIA-ALEGRIA E, Lafita-Navarro MC, Aguado R, Garcia-Gutierrez L, et al
    NUMB inactivation confers resistance to imatinib in chronic myeloid leukemia cells.
    Cancer Lett. 2016 Mar 2. pii: S0304-3835(16)30105.
    PubMed     Text format     Abstract available


  16. GERGES S, Rohde K, Fulda S
    Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cells.
    Cancer Lett. 2016 Mar 1. pii: S0304-3835(16)30108.
    PubMed     Text format     Abstract available


    February 2016
  17. SALEH AM, Taha MO, Aziz MA, Al-Qudah MA, et al
    Novel anticancer compound [trifluoromethyl-substituted pyrazole N-nucleoside] inhibits FLT3 activity to induce differentiation in acute myeloid leukemia cells.
    Cancer Lett. 2016 Feb 23. pii: S0304-3835(16)30096.
    PubMed     Text format     Abstract available


  18. SHINOHARA H, Kumazaki M, Minami Y, Ito Y, et al
    Perturbation of energy metabolism by fatty-acid derivative AIC-47 and imatinib in BCR-ABL-harboring leukemic cells.
    Cancer Lett. 2016;371:1-11.
    PubMed     Text format     Abstract available


    January 2016
  19. HUANG H, Jiang X, Wang J, Li Y, et al
    Identification of MLL-fusion/MYC dash, verticalmiR-26 dash, verticalTET1 signaling circuit in MLL-rearranged leukemia.
    Cancer Lett. 2016 Jan 11. pii: S0304-3835(16)00003.
    PubMed     Text format     Abstract available


    December 2015
  20. ELGEHAMA A, Chen W, Pang J, Mi S, et al
    Blockade of the interaction between Bcr-Abl and PTB1B by small molecule SBF-1 to overcome imatinib-resistance of chronic myeloid leukemia cells.
    Cancer Lett. 2015 Dec 22. pii: S0304-3835(15)00765.
    PubMed     Text format     Abstract available


  21. LIU X, Li Y, Wen L, Tao K, et al
    ABL SH3 mutant inhibits BCR-ABL activity and increases imatinib sensitivity by targeting RIN1 protein in CML cell.
    Cancer Lett. 2015;369:222-8.
    PubMed     Text format     Abstract available


  22. BINATO R, de Almeida Oliveira NC, Du Rocher B, Abdelhay E, et al
    The molecular signature of AML mesenchymal stromal cells reveals candidate genes related to the leukemogenic process.
    Cancer Lett. 2015;369:134-43.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: